基本信息
浏览量:106
职业迁徙
个人简介
Mervyn Bibb is a molecular microbiologist who has made a major contribution to our understanding of antibiotic production and its regulation by bacteria. The growing increase in antibiotic resistance seen in clinical pathogens has resulted in an urgent need for new anti-infective agents.
His research concentrates on Actinobacteria, the main source of clinically useful antibiotics. He invented technology for introducing DNA into these organisms, enabling researchers to not only understand in detail how antibiotics are made, but also to genetically manipulate the producing organisms to generate new compounds. More recently, he has applied genome sequencing and genomic approaches to identify gene clusters for several potentially clinically useful antibiotics.
Mervyn has published more than 180 research papers and presented his work at over 70 international conferences. He is the recipient of the Lepetit Award, the Colworth Prize, the Charles Thom Award and the Heatley Medal for his work on antibiotic biosynthesis. Research from his group led to the formation of two companies, Novacta Biosystems and Procarta Biosystems, each focused on developing new anti-infective treatments.
研究兴趣
论文共 29 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Juan Pablo Gomez-Escribano,Lis Algora Gallardo,Kenan A J Bozhüyük, Steven G Kendrew,Benjamin D Huckle, Nicola A Crowhurst,Mervyn J Bibb,Andrew J Collis,Jason Micklefield,Paul R Herron,Barrie Wilkinson
Microbial genomicsno. 11 (2021)
Applied and Environmental Microbiologyno. 3 (2020)
David Widdick, Sylvain F. Royer,Hua Wang,Natalia M. Vior,Juan Pablo Gomez-Escribano, Benjamin G. Davis,Mervyn J. Bibb
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn